The Healthcare Revolution 

The Healthcare Revolution is a docu-series that compiles interviews from over 100 of the world’s leading experts in stem cell research. Scientists and doctors from major private and public institutions, backed by governments and billions of dollars in research funding. These people are changing healthcare as we know it and will share it in this revolutionary series.

Take a minute to watch the trailer (scroll down the image on the left to start) and I think you’ll see for yourself just how powerful this series is. If you’d like to register, I’d encourage you to do so. All 10 episodes are free to watch.

You've heard so much about stem cells. But what do they really do?
a film by Amy Hardie and Clare Blackburn

Discover the history, evolution, and 'real science' of stem cell research in a documentary made in close collaboration between filmmakers and scientists.

(available on Amazon, YouTube, Vimeo)

Cell Surgical Network

AmpliCell is a part of Cell Surgical Network.

Dr. Mark Berman explains how stem cells can be extracted from fat and used to help regenerate injured areas. Optic Neuritis case.

Watch It Here

          The Cell Surgical Network is proud to have published one of the largest peer reviewed safety data papers on the use of autologous stromal vascular fraction (SVF) to date.
      The Cell Surgical Network set out to investigate the use of SVF for regenerative purposes, with an initial primary objective of evaluating safety (adverse events) in 1524 patients. Secondarily, this paper reports on efficacy. This study population accounts for 1698 overall SVF deployments, 1477 of which were intravenous.
      While the Cell Surgical Network aims to provide its patients the most personalized cellular medical care available, it needed to demonstrate that the surgery it practices is first and foremost safe. The Cell Surgical Network continues to make many advances in its investigational work, aggregating patient data and outcomes network-wide, consistently advancing cellular medicine along the way.

A Prospective Safety Study of Autologous Adipose-Derived Stromal Vascular Fraction Using a Specialized Surgical Processing System
Mark Berman, MD and Elliot Lander, MD

Read It Here
Cells from fat mend bone, cartilage, muscle and even the heart
Via Science News : Adipose tissue is a natural storehouse of healing cells.
Read It Here

Mark Berman, MD, Elliot Lander, MD, Jackie R. See, MD

Read It Here

Cell Expansion Study Approved
     Cell Surgical Network (CSN) has partnered with American Cryostem (ACS) and has recently received approval from ICSS to study the safety of banking and expanding adipose derived stromal vascular fraction.  Both companies see this as the future of regenerative medicine: bank young healthy cells and have them available when injury or illness occur.  A practice already well-established within the cord blood stem cell community, it seems natural to offer similar services for SVF.  For more information please visit:
Cell Surgical Network Study for Stromal Vascular Fraction Registered by

Rancho Mirage, CA (PRWEB) October 14, 2013, a service of the U.S. National Institutes of Health has registered on their public site an IRB approved safety study from the Cell Surgical Network, Inc.. This study is available for patients with various degenerative and inflammatory conditions to undergo Stromal Vascular Fraction deployment for the evaluation and for the advancement of future stem cell therapy procedures. Stromal Vascular Fraction is rich in autologous adipose derived stem cells and growth factors.

Stromal Vascular Fraction (SVF) is obtained by lipo-harvesting, procurement, and lipo-transfer as a same day operative procedure to provide therapy to patients with various degenerative and inflammatory diseases. Patients must be 16 years or older, male or female and have a degenerative disease or inflammatory disease that meets criteria for treatment under the IRB which includes: Arthritis, Auto-immune disease, COPD, Cardiomyopathy, Peyronies Disease, Interstitial Cystitis, Erectile Dysfunction, and Neurodegenerative disease such as Parkinson’s, ALS, Neuropathy. Patients must be healthy enough to tolerate a local anesthetic, must not have active cancer or infections.

Dr. Elliot Lander, and Dr. Mark Berman, founders of the Cell Surgical Network Inc. will conduct the study: “Ever since our inception, it’s been our goal to maintain transparency during our investigations. With a closed surgical procedure we can provide effective safety studies and evolve good empirical data that will allow us and others to ultimately refine our protocols,” says Dr. Berman.

The purpose of the safety study is to evaluate for any adverse effects that may be related to the administration and reception of autologous adipose derived stromal vascular fraction (SVF). Secondarily, the study monitors the results of subjective and objective findings as it applies to the non-blinded deployment of autologous SVF for various inflammatory and/or degenerative conditions including select orthopedic, neurologic, urologic and cardio-pulmonary conditions. SVF deployments include intra-venous, intra-articular, and soft tissue injections.

Outcome measures will include the number of participants with adverse events related to either SVF deployment or the lipo-harvesting procedure. Interested patients should contact the treatment center by phone: 800-231-0407 or via email: info(at)cellsurgicalnetwork(dot)com

About Cell Surgical Network:

The affiliates of the Cell Surgical Network (CSN) are devoted to advancing access and quality care in the area of adult stem cell regenerative medicine in order to help people suffering from a variety of inflammatory and degenerative conditions. The Cell Surgical Network was founded nearly two years after the formation of the California Stem Cell Treatment Center (founded in 2010). Affiliate members are generally made up of multi-state and international teams of multidisciplinary physicians in order to best assess and provide care for our patients. The Cell Surgical Network emphasizes quality and is highly committed to clinical research and the advancement of regenerative medicine. For more information, please visit:

Read more:

Concise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular Fraction.

Stem Cells Transl Med. 2017 Apr;6(4):1096-1108. doi: 10.1002/sctm.16-0337. Epub 2017 Jan 6.

Dykstra JA, Facile T, Patrick RJ, Francis KR, Milanovich S, Weimer JM, Kota DJ.



Due to their capacity to self-renew, proliferate and generate multi-lineage cells, adult-derived stem cells offer great potential for use in regenerative therapies to stop and/or reverse degenerative diseases such as diabetes, heart failure, Alzheimer's disease and others. However, these subsets of cells can be isolated from different niches, each with differing potential for therapeutic applications. The stromal vascular fraction (SVF), a stem cell enriched and adipose-derived cell population, has garnered interest as a therapeutic in regenerative medicine due to its ability to secrete paracrine factors that accelerate endogenous repair, ease of accessibility and lack of identified major adverse effects. Thus, one can easily understand the rush to employ adipose-derived SVF to treat human disease. Perhaps faster than any other cell preparation, SVF is making its way to clinics worldwide, while critical preclinical research needed to establish SVF safety, efficacy and optimal, standardized clinical procedures are underway. Here, we will provide an overview of the current knowledge driving this phenomenon, its regulatory issues and existing studies, and propose potential unmapped applications. Stem Cells Translational Medicine 2017;6:1096-1108.


Read It Here
Stem Cell Therapy for Thyroid Issues: A New Frontier
May 09, 2017
Read It Here
Brentwood woman able to walk again thanks to stem cell treatment -performed by CSN Affiliate Dr. Todd Malan
Read It Here
Sign up for the AmpliCell Newsletter to recieve the latest news, events and updates